Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

335

Participants

Timeline

Start Date

September 5, 2023

Primary Completion Date

June 25, 2029

Study Completion Date

June 25, 2029

Conditions
Asthma
Interventions
DRUG

Amlitelimab

Injection Solution: by subcutaneous injection (SCI)

DRUG

Placebo

Injection Solution: by subcutaneous injection (SCI)

Trial Locations (68)

1055

Investigational Site Number : 7100004, Middelburg

1060

Investigational Site Number : 0320009, Buenos Aires

1501

Investigational Site Number : 7100007, Benoni

2000

Investigational Site Number : 0320006, Rosario

2100

Investigational Site Number : 3480011, Gödöllö

2440

Investigational Site Number : 3480012, Százhalombatta

3780

Investigational Site Number : 3480009, Edelény

4150

Investigational Site Number : 3480006, Püspökladány

7530

Investigational Site Number : 7100002, Cape Town

7937

Investigational Site Number : 7100001, Cape Town

21224

Johns Hopkins University School of Medicine- Site Number : 8400012, Baltimore

31000

Investigational Site Number : 4840002, Chihuahua City

33025

Pines Care Research Center LLC- Site Number : 8400028, Pembroke Pines

33070

Investigational Site Number : 7920002, Mersin

33126

Savin Medical Group - Miami- Site Number : 8400015, Miami

33435

Helix Biomedics, LLC - Site Number : 8400029, Boynton Beach

34098

Investigational Site Number : 7920001, Istanbul

35100

Investigational Site Number : 7920003, Izmir

37134

Investigational Site Number : 3800001, Verona

38039

Investigational Site Number : 7920008, Kayseri

41100

Investigational Site Number : 7920005, Kocaeli

42415

Investigational Site Number : 4100004, Daegu

44100

Investigational Site Number : 4840001, Guadalajara

44670

Investigational Site Number : 4840005, Guadalajara

73034

OK Clinical Research, LLC- Site Number : 8400001, Edmond

78006

TTS Research- Site Number : 8400011, Boerne

80131

Investigational Site Number : 3800004, Naples

83706

Treasure Valley Medical Research- Site Number : 8400031, Boise

95207

Bensch Clinical Research LLC- Site Number : 8400004, Stockton

97070

Investigational Site Number : 4840008, Mérida

2260877

Investigational Site Number : 1520005, Quillota

3465584

Investigational Site Number : 1520006, Talca

7500692

Investigational Site Number : 1520001, Santiago

7750495

Investigational Site Number : 1520003, Santiago

8380465

Investigational Site Number : 1520008, Santiago

C1425FVH

Investigational Site Number : 0320002, CABA

B1900BNN

Investigational Site Number : 0320008, La Plata

S2000DEJ

Investigational Site Number : 0320007, Rosario

S2000JKR

Investigational Site Number : 0320005, Rosario

C1121ABE

Investigational Site Number : 0320004, Ciudad Autonoma Bs As

C1414AIF

Investigational Site Number : 0320003, Ciudad Autonoma Buenos Aires

C1425BEN

Investigational Site Number : 0320001, Ciudad Autonoma Buenos Aires

29055-450

Centro de Diagnostico e Pesquisa da Osteoporose do Espirito Santo- Site Number : 0760002, Vitória

40060-330

Proar- Site Number : 0760004, Salvador

99010-170

Instituto Méderi de Pesquisa e Saúde- Site Number : 0760001, Passo Fundo

90020-090

Irmandade da Santa Casa de Misericordia de Porto Alegre- Site Number : 0760007, Porto Alegre

90610-000

Hospital Sao Lucas da PUCRS- Site Number : 0760006, Porto Alegre

05403-000

Hospital das Clinicas de Sao Paulo- Site Number : 0760008, São Paulo

18040-425

Clínica de Alergia Martti Antila- Site Number : 0760003, Sorocaba

K1G 6C6

Investigational Site Number : 1240008, Ottawa

G8T 7A1

Investigational Site Number : 1240007, Trois-Rivières

00168

Investigational Site Number : 3800003, Rome

591-8555

Investigational Site Number : 3920010, Sakai

103-0027

Investigational Site Number : 3920005, Chuo-ku

104-0031

Investigational Site Number : 3920004, Chuo-ku

140-8522

Investigational Site Number : 3920001, Shinagawa-ku

732-0052

Investigational Site Number : 3920019, Hiroshima

60-693

Investigational Site Number : 6160001, Poznan

31-559

Investigational Site Number : 6160006, Krakow

15-044

Investigational Site Number : 6160004, Bialystok

82-300

Investigational Site Number : 6160003, Elblag

80-405

Investigational Site Number : 6160002, Gdansk

33-100

Investigational Site Number : 6160007, Tarnów

E1C 6Z8

Investigational Site Number : 4100006, Moncton

03722

Investigational Site Number : 4100001, Seoul

05030

Investigational Site Number : 4100005, Seoul

138-878

Investigational Site Number : 4100002, Seoul

BD9 6RJ

Investigational Site Number : 8260001, Bradford

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY